Phase I-II

© Getty Images

Clinical Trials Day 2023

Clinical trial diversity - a Q&A with Clincierge

By Liza Laws

The US Food and Drug Administration will soon require researchers and companies seeking approval for late-stage clinical trials to submit a diversity plan for trial participants. Scott Gray, CEO of Clincierge, discusses how trial sponsors and CROs can...

Follow us

Product Innovations